From: Impact of 18F FDG PET/CT on management of incidental gallbladder carcinoma
Patient No | Age (years) | Sex | Histological type | Grade | Margin | Pathological staging |
---|---|---|---|---|---|---|
1 | 42 | F | Adenocarcinoma | Not available | Not available | T2bNx |
2 | 57 | M | Adenocarcinoma | G1 | R0 | T1bNx |
3 | 61 | F | Adenocarcinoma | Not available | Not available | T3NxMx |
4 | 59 | F | Adenocarcinoma | Not available | Not available | T2bNx |
5 | 38 | M | Adenocarcinoma | G1 | R0 | T2Nx |
6 | 63 | F | Neuroendocrine | G3 | Not available | T2aNx |
7 | 50 | F | Adenocarcinoma | Not available | Not available | T2aNx |
8 | 55 | F | Adenocarcinoma | G1 | R1 | T1bNx |
9 | 61 | M | Adenocarcinoma | G1 | R0 | T3Nx |
10 | 61 | F | Adenocarcinoma | G2 | R0 | T2Nx |
11 | 55 | F | Adenocarcinoma | G2 | Not available | T1aNx |
12 | 54 | M | Adenocarcinoma | Not available | Not available | T3Nx |
13 | 76 | M | Adenocarcinoma | G2 | Not available | T2N0 |
14 | 47 | F | Adenocarcinoma | G1 | Not available | T2bN0 |
15 | 66 | M | Adenocarcinoma | G1 | Not available | T2bNx |
16 | 42 | F | Adenocarcinoma | G1 | Not available | T2bNx |
17 | 50 | F | Adenocarcinoma | G1 | Not available | T2N0 |